Filing Details
- Accession Number:
- 0001144204-18-055025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-23 19:13:23
- Reporting Period:
- 2018-10-22
- Accepted Time:
- 2018-10-23 19:13:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557746 | Aclaris Therapeutics Inc. | ACRS | Pharmaceutical Preparations (2834) | 460571712 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590102 | Anand Mehra | 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-22 | 372,093 | $10.75 | 1,911,573 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Such shares of the Company's Common Stock are owned by Sofinnova Venture Partners VIII, L.P. ("Sofinnova VIII"). The Reporting Person is a managing member of Sofinnova Management VIII, L.L.C., the general partner of Sofinnova VIII, and as such may be deemed to have shared voting and dispositive power over such shares with James I. Healy and Michael F. Powell, the other managing members of Sofinnova Management VIII, L.L.C. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein.
Billionaire Hedge Funds
